CRISPR safeguard changes how engineered microbes can be controlled - Phys.org

CRISPR safeguard changes how engineered microbes can be controlled  Phys.org

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the S...

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?  The Motley Fool

New CRISPR RNA scissors specifically target and destroy hepatitis E virus - News-Medical

New CRISPR RNA scissors specifically target and destroy hepatitis E virus  News-Medical

CRISPR-based Gene Editing Market Size to Hit USD 28.77 Billion by 2035 - BioSpace

CRISPR-based Gene Editing Market Size to Hit USD 28.77 Billion by 2035  BioSpace

RNA-triggered cell killing with CRISPR–Cas12a2 - Nature

RNA-triggered cell killing with CRISPR–Cas12a2  Nature

$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy - Live Science

$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy  Live Science

USU Biochemists Show CRISPR Can Selectively Destroy Cells, a Cancer-Treatment Goal - Utah State U...

USU Biochemists Show CRISPR Can Selectively Destroy Cells, a Cancer-Treatment Goal  Utah State University

New Kind of CRISPR Could Treat Viral Infection and Cancer by Shredding Sick Cells’ DNA - Universi...

New Kind of CRISPR Could Treat Viral Infection and Cancer by Shredding Sick Cells’ DNA  University of Utah Health

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial - CNBC

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial  CNBC

CRISPR takes a bold leap toward silencing Down syndrome's extra chromosome - Medical Xpress

CRISPR takes a bold leap toward silencing Down syndrome's extra chromosome  Medical Xpress

A Look At CRISPR Therapeutics (CRSP) Valuation As CASGEVY Progress And New Funding Lift Investor ...

A Look At CRISPR Therapeutics (CRSP) Valuation As CASGEVY Progress And New Funding Lift Investor Interest  simplywall.st

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the S...

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?  AOL.com

CRISPR Market Size, Share | Industry Report [2026-2034] - Fortune Business Insights

CRISPR Market Size, Share | Industry Report [2026-2034]  Fortune Business Insights

NIH-funded breakthrough shrinks CRISPR for precision delivery in the body - National Institutes o...

NIH-funded breakthrough shrinks CRISPR for precision delivery in the body  National Institutes of Health (.gov)

Next Generation CRISPR Gene Editing Could Help Target Cancer Cells - Inside Precision Medicine

Next Generation CRISPR Gene Editing Could Help Target Cancer Cells  Inside Precision Medicine

Evercore Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Raises Target Price to $76 - Moomoo

Evercore Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Raises Target Price to $76  Moomoo

CRISPR gene editing and its application - Britannica

CRISPR gene editing and its application  Britannica

Intellia in the spotlight: Earnings test follows CRISPR milestone - Investing.com

Intellia in the spotlight: Earnings test follows CRISPR milestone  Investing.com

CRISPR tool targets cancer and virus-infected cells precisely - healthcare-in-europe.com

CRISPR tool targets cancer and virus-infected cells precisely  healthcare-in-europe.com

DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage - Nature

DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage  Nature

Personalized CRISPR therapies could soon reach thousands — here’s how - Nature

Personalized CRISPR therapies could soon reach thousands — here’s how  Nature

CRISPR-based platform pinpoints drivers of leukemia in patient cells - Penn Medicine

CRISPR-based platform pinpoints drivers of leukemia in patient cells  Penn Medicine

CRISPR Blocks Hepatitis E Virus - Mirage News

CRISPR Blocks Hepatitis E Virus  Mirage News

A new kind of CRISPR could treat viral infection and cancer by shredding sick cells' DNA - Phys.org

A new kind of CRISPR could treat viral infection and cancer by shredding sick cells' DNA  Phys.org

CRISPR Therapeutics (NASDAQ:CRSP) Upgraded to Hold at Wall Street Zen - MarketBeat

CRISPR Therapeutics (NASDAQ:CRSP) Upgraded to Hold at Wall Street Zen  MarketBeat

Nwam LLC Has $3.38 Million Position in CRISPR Therapeutics AG $CRSP - MarketBeat

Nwam LLC Has $3.38 Million Position in CRISPR Therapeutics AG $CRSP  MarketBeat

Human pluripotent stem cell engineering with CRISPR–Cas9 for Parkinson’s disease - Nature

Human pluripotent stem cell engineering with CRISPR–Cas9 for Parkinson’s disease  Nature

CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease - The New Engl...

CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease  The New England Journal of Medicine

Structural basis of supercoiling-induced CRISPR–Cas9 off-target activity - Nature

Structural basis of supercoiling-induced CRISPR–Cas9 off-target activity  Nature

In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differen...

In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation  Rockefeller University Press

Single-cell multiplex approaches deeply map ON-target CRISPR-genotoxicity and reveal its mitigati...

Single-cell multiplex approaches deeply map ON-target CRISPR-genotoxicity and reveal its mitigation by palbociclib and long-term engraftment  Nature

Identification of proteins influencing CRISPR-associated transposases for enhanced genome editing...

Identification of proteins influencing CRISPR-associated transposases for enhanced genome editing  Science | AAAS

CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates - Yahoo Finance

CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates  Yahoo Finance

Therapeutic applications of CRISPR-Cas9 gene editing - Frontiers

Therapeutic applications of CRISPR-Cas9 gene editing  Frontiers

New study reveals CRISPR enzyme that responds to human DNA methylation - News-Medical

New study reveals CRISPR enzyme that responds to human DNA methylation  News-Medical

CRISPR/Cas9-mediated gene correction of Wilson disease H1069Q point mutation in patient-specific ...

CRISPR/Cas9-mediated gene correction of Wilson disease H1069Q point mutation in patient-specific induced pluripotent stem cells  Nature

CRISPR makes enhanced cancer-fighting immune cells inside mice - Nature

CRISPR makes enhanced cancer-fighting immune cells inside mice  Nature

CRISPR Technology Shows Promise in Inhibiting Hepatitis E Virus - Bioengineer.org

CRISPR Technology Shows Promise in Inhibiting Hepatitis E Virus  Bioengineer.org

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 - The New England Journal of Medicine

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3  The New England Journal of Medicine

Computation and deep-learning-driven advances in CRISPR genome editing - Nature

Computation and deep-learning-driven advances in CRISPR genome editing  Nature

Towards CRISPR-based editing of the mitochondrial genome in yeast - PNAS

Towards CRISPR-based editing of the mitochondrial genome in yeast  PNAS

Characterizing and controlling CRISPR repair outcomes in nondividing human cells - Nature

Characterizing and controlling CRISPR repair outcomes in nondividing human cells  Nature

Human liver disease and the evolving role of CRISPR/Cas9 - Mayo Clinic

Human liver disease and the evolving role of CRISPR/Cas9  Mayo Clinic

Is It Time To Reassess CRISPR Therapeutics (CRSP) After Its 58% One-Year Surge? - simplywall.st

Is It Time To Reassess CRISPR Therapeutics (CRSP) After Its 58% One-Year Surge?  simplywall.st

High-content CRISPR activation screens identify synthetically lethal RNA-based mechanisms to sens...

High-content CRISPR activation screens identify synthetically lethal RNA-based mechanisms to sensitize cancer cells to targeted T cell cytotoxicity  Nature

The baby whose life was saved by the first personalized CRISPR therapy - Nature

The baby whose life was saved by the first personalized CRISPR therapy  Nature

CRISPR-Cas–mediated heritable chromosome fusions in Arabidopsis - Science | AAAS

CRISPR-Cas–mediated heritable chromosome fusions in Arabidopsis  Science | AAAS

The promise of gene editing with CRISPR - Van Andel Institute

The promise of gene editing with CRISPR  Van Andel Institute

AI-powered CRISPR could lead to faster gene therapies, Stanford Medicine study finds - Stanford M...

AI-powered CRISPR could lead to faster gene therapies, Stanford Medicine study finds  Stanford Medicine

The Chemistry of Genome Editing: Transforming Human and Planet Health with CRISPR - C&EN

The Chemistry of Genome Editing: Transforming Human and Planet Health with CRISPR  C&EN

Cutting to the chase with CRISPR - HDBuzz

Cutting to the chase with CRISPR  HDBuzz

CRISPR–Cas3-based editing for targeted deletions in a mouse model of transthyretin amyloidosis - ...

CRISPR–Cas3-based editing for targeted deletions in a mouse model of transthyretin amyloidosis  Nature

Measurement and clinical interpretation of CRISPR off-targets - Nature

Measurement and clinical interpretation of CRISPR off-targets  Nature

Harnessing artificial intelligence to advance CRISPR-based genome editing technologies - Nature

Harnessing artificial intelligence to advance CRISPR-based genome editing technologies  Nature

‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree? - Nature

‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree?  Nature

Could CRISPR really cure these diseases? - Labiotech.eu

Could CRISPR really cure these diseases?  Labiotech.eu

Democratizing CRISPR? Legal complexity, access and the right to science - Nature

Democratizing CRISPR? Legal complexity, access and the right to science  Nature

Highlight: CRISPR Gene Editing Exposes Hidden Switch in Inflammatory Receptor - CRISPR Medicine News

Highlight: CRISPR Gene Editing Exposes Hidden Switch in Inflammatory Receptor  CRISPR Medicine News

First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides - w...

First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides  www.heart.org

How CRISPR Gene Editing Saved Baby KJ - National Press Foundation

How CRISPR Gene Editing Saved Baby KJ  National Press Foundation

CRISPR vs cholesterol: can gene editing prevent heart disease? - Nature

CRISPR vs cholesterol: can gene editing prevent heart disease?  Nature

Rewriting the Hemoglobin Switch: CRISPR Targeting in Sickle Cell Disease - CancerNetwork

Rewriting the Hemoglobin Switch: CRISPR Targeting in Sickle Cell Disease  CancerNetwork

Perspective of smart nanocapsule swallowable laser-guided for integrated sensing and crispr-media...

Perspective of smart nanocapsule swallowable laser-guided for integrated sensing and crispr-mediated cancer gene editing | Cancer Gene Therapy  Nature

Crispr Therapeutics AG (CRSP) Gets a Buy from Piper Sandler - The Globe and Mail

Crispr Therapeutics AG (CRSP) Gets a Buy from Piper Sandler  The Globe and Mail

Small Nuclear RNA Base Editing a Safer Alternative to CRISPR, UC San Diego Researchers Find - UC ...

Small Nuclear RNA Base Editing a Safer Alternative to CRISPR, UC San Diego Researchers Find  UC San Diego Today

An updated evolutionary classification of CRISPR–Cas systems including rare variants - Nature

An updated evolutionary classification of CRISPR–Cas systems including rare variants  Nature

Ethical dimensions and societal implications: ensuring the social responsibility of CRISPR techno...

Ethical dimensions and societal implications: ensuring the social responsibility of CRISPR technology  Frontiers

Souped-Up CRISPR Gene Editor Replicates and Spreads Like a Virus - SingularityHub

Souped-Up CRISPR Gene Editor Replicates and Spreads Like a Virus  SingularityHub

This CRISPR breakthrough turns genes on without cutting DNA - ScienceDaily

This CRISPR breakthrough turns genes on without cutting DNA  ScienceDaily

Revolutionizing CRISPR technology with artificial intelligence - Nature

Revolutionizing CRISPR technology with artificial intelligence  Nature

CRISPR-GPT for agentic automation of gene-editing experiments - Nature

CRISPR-GPT for agentic automation of gene-editing experiments  Nature

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - Y...

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results  Yahoo Finance

Advancing CRISPR with deep learning: A comprehensive review of models and databases - ScienceDire...

Advancing CRISPR with deep learning: A comprehensive review of models and databases  ScienceDirect.com

Advances in large-scale DNA engineering with the CRISPR system - Nature

Advances in large-scale DNA engineering with the CRISPR system  Nature

CRISPR technology’s next wave: Ten companies to watch in 2025 - Labiotech.eu

CRISPR technology’s next wave: Ten companies to watch in 2025  Labiotech.eu

Customizing CRISPR–Cas PAM specificity with protein language models - Nature

Customizing CRISPR–Cas PAM specificity with protein language models  Nature

Reprogramming CRISPR–Cas enzymes for customized genome editing - Nature

Reprogramming CRISPR–Cas enzymes for customized genome editing  Nature

Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments - WIRED

Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments  WIRED

Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Choles...

Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides  Cleveland Clinic

CRISPR targeting of H3K4me3 activates gene expression and unlocks centromere-proximal crossover r...

CRISPR targeting of H3K4me3 activates gene expression and unlocks centromere-proximal crossover recombination in Arabidopsis  Nature

Nobel Prize winners face new loss in bid for US CRISPR patents - Reuters

Nobel Prize winners face new loss in bid for US CRISPR patents  Reuters

Scientists just made CRISPR three times more effective - ScienceDaily

Scientists just made CRISPR three times more effective  ScienceDaily

Modified CRISPR tool targets Down syndrome mutation - Labiotech.eu

Modified CRISPR tool targets Down syndrome mutation  Labiotech.eu

Parents of children with rare diseases ask: How long until our CRISPR miracle? - statnews.com

Parents of children with rare diseases ask: How long until our CRISPR miracle?  statnews.com

CRISPR and RNA interference: revolutionary tools for extending food shelf life and ensuring safet...

CRISPR and RNA interference: revolutionary tools for extending food shelf life and ensuring safety  Frontiers

Engineered Miniature CRISPR Boosts Gene‑Editing Efficiency in Human Cells - Genetic Engineering a...

Engineered Miniature CRISPR Boosts Gene‑Editing Efficiency in Human Cells  Genetic Engineering and Biotechnology News

Press Release Service: Vertex Reports First Quarter 2026 Financial Results - CRISPR Medicine News

Press Release Service: Vertex Reports First Quarter 2026 Financial Results  CRISPR Medicine News

Applications of multiplexed CRISPR–Cas for genome engineering - Nature

Applications of multiplexed CRISPR–Cas for genome engineering  Nature

First CRISPR horses spark controversy: what’s next for gene-edited animals? - Nature

First CRISPR horses spark controversy: what’s next for gene-edited animals?  Nature

Berkeley Talks: Nobel laureate Jennifer Doudna on CRISPR and the future of gene editing - Univers...

Berkeley Talks: Nobel laureate Jennifer Doudna on CRISPR and the future of gene editing  University of California, Berkeley

CRISPR gene-editing works to reduce high cholesterol in a new study - NPR

CRISPR gene-editing works to reduce high cholesterol in a new study  NPR

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 6.1% - What's Next? - MarketBeat

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 6.1% - What's Next?  MarketBeat

In Vivo Gene Editing Market (2026-2035) | Genetic Engineering, - openPR.com

In Vivo Gene Editing Market (2026-2035) | Genetic Engineering,  openPR.com

Blueprints for a molecular machine more powerful than CRISPR - Purdue University

Blueprints for a molecular machine more powerful than CRISPR  Purdue University

The hidden risks of CRISPR/Cas: structural variations and genome integrity - Nature

The hidden risks of CRISPR/Cas: structural variations and genome integrity  Nature

Design of highly functional genome editors by modelling CRISPR–Cas sequences - Nature

Design of highly functional genome editors by modelling CRISPR–Cas sequences  Nature

RNA-guided CRISPR system activates gene expression - Phys.org

RNA-guided CRISPR system activates gene expression  Phys.org

News: CMN Weekly (17 October 2025) - Your Weekly CRISPR Medicine News - CRISPR Medicine News

News: CMN Weekly (17 October 2025) - Your Weekly CRISPR Medicine News  CRISPR Medicine News

LeDNA: a cut-and-build toolkit to democratize CRISPR gene editing technology education - Nature

LeDNA: a cut-and-build toolkit to democratize CRISPR gene editing technology education  Nature

AI expands the repertoire of CRISPR-associated proteins for genome editing - Nature

AI expands the repertoire of CRISPR-associated proteins for genome editing  Nature